http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007022305-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8d39658098ebea577fe2c2b690824345
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7d6949fe6faa45df79f04cc5698e8167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0f33ddbf1c5ae9d800ef74612ee97729
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_da3b9774acd7f22029a496150ce3c64e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_456735094c1a0ba3df0172aae487d5b6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_90b6a94203592576ea1f73ac2c925ec0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b66335db9e47f67d17aa2ac732642c25
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4188
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
filingDate 2006-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af74f6402e5516432118c124a8b87415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b3ada846a8362b2d053dde1a683c8dc9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_194d5c67d593ab8de8b8b9534398cea4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_659b37bd0b80d16374c98c1cdd6151a3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0abc4dbffd58838cb7a4d4435e66a4f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_adc7cdd90c25992319abd90b122ceec6
publicationDate 2007-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2007022305-A3
titleOfInvention 2-aminoimidazopyridines for treating neurodegenerative diseases
abstract The invention relates to 2-aminoimidazopyridine derivatives useful in treating disorders that are mediated by A2a receptor function, including neurodegenerative diseases including Parkinson's disease and inflammation. The compounds have general formula (I).
priorityDate 2005-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006027366-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005100353-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422062067
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID179897
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226427111

Total number of triples: 30.